Schroeder S, Lindemann C, Hoeft A, Putensen C, Decker D, von Ruecker A A, Stüber F
Klinik und Poliklinik für Anästhesiologie und Spezielle Intensivmedizin, der Friedrich-Wilhelms-Universität Bonn, Germany.
Crit Care Med. 1999 Jun;27(6):1080-4. doi: 10.1097/00003246-199906000-00023.
To determine the extent of the potentially protective heat shock protein 70 response in peripheral blood lymphocytes of patients with severe sepsis after ex vivo lipopolysaccharide stimulation.
Entry study of consecutive patients with severe sepsis, those who were critically ill or nonseptic after major surgery, and healthy blood donors.
Surgical intensive care unit in a university hospital.
Ten patients with diagnoses of severe sepsis; ten critically ill, nonseptic patients after major surgery; and ten healthy blood donors.
None.
We investigated the ex vivo endotoxin-inducible expression of heat shock protein 70 in peripheral blood lymphocytes of patients with severe sepsis by means of flow cytometry. Only negligible amounts of inducible intracellular heat shock protein 70 accumulation (<4.2% of lymphocytes) could be detected in peripheral blood lymphocytes without lipopolysaccharide stimulation. The proportion of cells accumulating heat shock protein 70 after treatment with lipopolysaccharide was distinctly lower in patients with severe sepsis (p < .05) than in critically ill, nonseptic patients after major surgery and healthy blood donors (38.3+/-3.3%, 82.2+/-4.5%, and 70.9+/-3.9%, respectively; mean +/- SEM; n = 10). Patients with clinical signs of recovery from severe sepsis showed an increase in heat shock protein 70 expression.
Inducibility of ex vivo heat shock protein 70 was impaired in peripheral blood lymphocytes of patients with severe sepsis. The impaired expression of the potentially protective heat shock protein 70 may contribute in vivo to immune dysfunction, because intact functioning of T and B lymphocyte responses is of central importance in resisting infection in severe sepsis. Monitoring of inducible heat shock protein 70 in peripheral blood lymphocytes may contribute to the evaluation of the immune consequences of severe sepsis.
确定严重脓毒症患者外周血淋巴细胞在体外脂多糖刺激后潜在的保护性热休克蛋白70反应的程度。
对连续的严重脓毒症患者、大手术后危重症或非脓毒症患者以及健康献血者进行的入组研究。
大学医院的外科重症监护病房。
10例诊断为严重脓毒症的患者;10例大手术后危重症、非脓毒症患者;以及10名健康献血者。
无。
我们通过流式细胞术研究了严重脓毒症患者外周血淋巴细胞中热休克蛋白70的体外内毒素诱导表达。在未进行脂多糖刺激的外周血淋巴细胞中,仅能检测到可忽略不计的诱导性细胞内热休克蛋白70积累(<4.2%的淋巴细胞)。严重脓毒症患者经脂多糖处理后积累热休克蛋白70的细胞比例明显低于大手术后危重症、非脓毒症患者及健康献血者(分别为38.3±3.3%、82.2±4.5%和70.9±3.9%;均值±标准误;n = 10)(p <.05)。有严重脓毒症恢复临床体征的患者热休克蛋白70表达增加。
严重脓毒症患者外周血淋巴细胞中热休克蛋白70的体外诱导能力受损。潜在保护性热休克蛋白70表达受损可能在体内导致免疫功能障碍,因为T和B淋巴细胞反应的完整功能在严重脓毒症抵抗感染中至关重要。监测外周血淋巴细胞中诱导性热休克蛋白70可能有助于评估严重脓毒症的免疫后果。